B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NOX1

MOLECULAR TARGET

NADPH oxidase 1

UniProt: Q9Y5S8NCBI Gene: 270353 compounds

NOX1 (NADPH oxidase 1) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NOX1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1ebselen4.74113
2diphenyleneiodonium chloride2.4811
3celastrol0.691

About NOX1 as a Drug Target

NOX1 (NADPH oxidase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented NOX1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NOX1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.